Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07291427 · ClinicalTrials.gov registry record
Chronic Subdural Hematoma Embolization With Detachable Coils
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Not yet
- Registry status
- 150
- Enrollment target
NCT07291427: Clinical Trial study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT07291427 is a clinical trial that has not yet begun recruiting, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07291427 has not yet begun recruiting, sponsored by Icahn School of Medicine at Mount Sinai.
- NOT YET RECRUITING
- Registry status
- 150 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, post market registry study designed to evaluate the safety and efficacy of treatment with Balt coils in patients with chronic subdural hematoma (cSDH).
Primary Outcome
Change in hematoma volume based on CT imaging
Interventions
- DEVICE Balt coils: (Balt USA, LLC)
- PROCEDURE MMA embolization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2028-09-01 |
What is known before NCT07291427 opens enrollment
NCT07291427 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Balt coils: (Balt USA, LLC) is the first listed.
NCT07291427 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07291427 about?
NCT07291427 is a clinical study titled "Chronic Subdural Hematoma Embolization With Detachable Coils". This is a prospective, multi-center, post market registry study designed to evaluate the safety and efficacy of treatment with Balt coils in patients with chronic subdural hematoma (cSDH).
What is the current status of trial NCT07291427?
This trial is currently not yet recruiting. The enrollment target is 150 participants. The study started on 2026-07-01. Estimated completion is 2028-09-01.
What interventions are being tested in trial NCT07291427?
The interventions under investigation include: Balt coils: (Balt USA, LLC) (DEVICE), MMA embolization (PROCEDURE).
Who is sponsoring clinical trial NCT07291427?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI